Amgen: all 1,085 studies

Page 9 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)CompletedNCT02103283Phase 1
• Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone DiseaseWithdrawnNCT02101164Phase 4
• A Phase 1/2 Study Evaluating AMG 337 in Asian SubjectsCompletedNCT02096666Phase 1/2
• Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration TrainingCompletedNCT02085993
• A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple MyelomaCompletedNCT02072863Phase 1/2
• Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in DenmarkCompletedNCT02066805
• Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid TumorsTerminatedNCT02016534Phase 2
• Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia PatientsCompletedNCT02010931
• Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic LeukemiaCompletedNCT02003612
• Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the JawCompletedNCT01998607
• AMG 386 Drug-Drug Interaction Study With PaclitaxelCompletedNCT01992341Phase 1
• Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic AcidCompletedNCT01967160
• Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis SubjectsTerminatedNCT01962337Phase 1
• Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With MigrainesCompletedNCT01953341Phase 1
• A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.CompletedNCT01928368Phase 1
• Multiple Ascending Dose Study in Subjects With Type 2 DiabetesTerminatedNCT01856881Phase 1
• Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJCompletedNCT01791374Phase 1
• Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in EuropeCompletedNCT01791361
• Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus SubjectsTerminatedNCT01755442Phase 1
• First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaTerminatedNCT01697072Phase 3
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy SubjectsCompletedNCT01695876Phase 1
• Safety Study of AMG 557 in Subjects With Lupus ArthritisCompletedNCT01683695Phase 1
• Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01666977Phase 1/2
• Osteonecrosis of the Jaw (ONJ) Case RegistryCompletedNCT01666106
• European Physician Survey of EGFR Inhibitor Prescribing PatternsCompletedNCT01652833
• 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)TerminatedNCT01568229Phase 2
• 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsTerminatedNCT01568216Phase 2
• First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable SchizophreniaTerminatedNCT01568203Phase 1
• AMG 761 in Adults With AsthmaTerminatedNCT01514981Phase 1
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With PsoriasisCompletedNCT01510951Phase 1
• AMG 172 First in Human Study in Patients With Kidney CancerCompletedNCT01497821Phase 1
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With PsoriasisTerminatedNCT01493518Phase 1
• TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerTerminatedNCT01493505Phase 3
• Single Ascending Dose Trial in Patients With Type 2 DiabetesTerminatedNCT01492465Phase 1
• AMG 595 First-in-Human in Recurrent GliomasCompletedNCT01475006Phase 1
• AMG 151 Amgen Protocol Number 20100761CompletedNCT01464437Phase 2
• A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic NephropathyCompletedNCT01447147Phase 2
• A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and AlbuminuriaCompletedNCT01440257Phase 2
• Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney DiseaseWithdrawnNCT01428154Phase 1
• Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic MalignanciesTerminatedNCT01416428Phase 1/2
• Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory DiseaseApproved for marketingNCT01410500
• Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With AsthmaWithdrawnNCT01395485Phase 1
• Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusTerminatedNCT01389895Phase 1
• Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid TumorsCompletedNCT01386866Phase 1
• Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid LeukemiaCompletedNCT01380756Phase 1
• A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal FunctionCompletedNCT01331941Phase 1
• To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCompletedNCT01300208Phase 2
• AMG 319 Lymphoid Malignancy FIHCompletedNCT01300026Phase 1
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.CompletedNCT01290042Phase 1
• AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)TerminatedNCT01281254Phase 3
• A Study of AMG 337 in Subjects With Advanced Solid TumorsCompletedNCT01253707Phase 1
• Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCompletedNCT01253681Phase 1
• Study of FP-1039 in Subjects With Endometrial CancersWithdrawnNCT01244438Phase 2
• A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate TherapyCompletedNCT01242917Phase 2
• A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid TumorsCompletedNCT01235416Phase 1
• TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCompletedNCT01204749Phase 3
• Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusTerminatedNCT01164917Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative ColitisTerminatedNCT01164904Phase 1
• Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With AsthmaCompletedNCT01137565Phase 1
• A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid TumorsTerminatedNCT01137552Phase 1
• Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100CompletedNCT01135680Phase 1
• Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid TumorsCompletedNCT01129349Phase 1
• Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult SubjectsCompletedNCT01124279Phase 1
• An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral DensityCompletedNCT01101048Phase 1
• A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes MellitusCompletedNCT01028963Phase 2
• Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid ArthritisCompletedNCT01027728Phase 1/2
• AMG 853 Phase 2 Study in Subjects With Inadequately Controlled AsthmaCompletedNCT01018550Phase 2
• A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control GroupCompletedNCT00986895Phase 1
• A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)CompletedNCT00977600Phase 1
• AMG 745 in Subjects With Age-associated Muscle LossWithdrawnNCT00975104Phase 2
• A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary HyperparathyroidismCompletedNCT00936988Phase 2
• A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)CompletedNCT00936650Phase 2
• IMPACT Non Hodgkins Lymphoma (NHL) StudyCompletedNCT00903812
• A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal WomenCompletedNCT00902356Phase 1
• A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCompletedNCT00872014Phase 2
• Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver MetastasesCompletedNCT00866944Phase 2
• To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.CompletedNCT00861419Phase 1
• Effects of Long-term Dosing of AMG 531 on Bone Marrow MorphologyCompletedNCT00861224
• A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid TumorsCompletedNCT00858377Phase 1
• "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"CompletedNCT00840333Phase 1
• Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisCompletedNCT00818948Phase 1
• A Phase 1 Study of AMG 208 in Subjects With Advanced Solid TumorsCompletedNCT00813384Phase 1
• Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerCompletedNCT00807859Phase 1
• Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or VorinostatCompletedNCT00791011Phase 1
• A Study of AMG 557 in Adults With Systemic Lupus ErythematosusCompletedNCT00774943Phase 1
• AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate CancerCompletedNCT00770848Phase 1/2
• AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRCompletedNCT00770536Phase 1
• A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)CompletedNCT00756860Phase 1
• A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00752570Phase 2
• A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00752414Phase 1
• AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction CancerCompletedNCT00719550Phase 1/2
• Safety Study of FP-1039 To Treat CancerCompletedNCT00687505Phase 1
• A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes MellitusWithdrawnNCT00661921Phase 2
• Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian CancerCompletedNCT00635596Phase 1
• Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue SarcomaCompletedNCT00626704Phase 1/2
• Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal CancerCompletedNCT00625651Phase 1/2
• Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type PsoriasisCompletedNCT00606450Phase 2
• Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type PsoriasisCompletedNCT00604682Phase 2
• Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal AdenocarcinomaCompletedNCT00583674Phase 2
• AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaCompletedNCT00562380Phase 1

← Amgen overview and focus areas